LEMPMAR: Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy

Sponsor
Fondation Ophtalmologique Adolphe de Rothschild (Other)
Overall Status
Completed
CT.gov ID
NCT02895581
Collaborator
(none)
34

Study Details

Study Description

Brief Summary

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    34 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Study Start Date :
    Jan 1, 2006
    Actual Primary Completion Date :
    Jan 1, 2015

    Outcome Measures

    Primary Outcome Measures

    1. Rankin score [12 months after diagnosis of leukoencephalopathy]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • HIV infected patients

    • Diagnosed with progressive multifocal leukoencephalopathy

    • Minimal follow-up of one year OR patient deceased less than one year after diagnosis

    Exclusion Criteria:
    • Loss of follow-up within 12 months after diagnosis

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Fondation Ophtalmologique Adolphe de Rothschild

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fondation Ophtalmologique Adolphe de Rothschild
    ClinicalTrials.gov Identifier:
    NCT02895581
    Other Study ID Numbers:
    • NI_AMR_2015_1
    First Posted:
    Sep 9, 2016
    Last Update Posted:
    Sep 9, 2016
    Last Verified:
    Sep 1, 2016

    Study Results

    No Results Posted as of Sep 9, 2016